|
|
|
 |
Sepax System
The processing step is one of the most important and involves separating the stem cell-containing 'buffy coat' component from the other components, such as red blood cells and plasma.
During this separation procedure, the cord blood is spun to create a centrifugal force that separates the components based on their density.
Previously, this procedure was performed manually using a transfer set, syringes and a centrifuge.
For the last few years, there has been a move in both public and private banks to standardize this process through automation and today a large majority of the top banks around the world use the same cord blood processing technology - SEPAX.
The Sepax System is made in Switzerland by Biosafe, an FDA-registered manufacturer.
Sepax is unique as it requires neither additional equipment, such as a separated centrifuge, nor operator intervention during the separation procedure - this significantly reduces risk of cross-contamination as well as operator error.
In addition, Sepax transfers the buffy coat component to the final storage cryobag while the cord blood is being spun (see Sepax animation) which ensures smooth and precise separation of the components.
Sepax is, not only, the most tried and trusted automated cord blood processing technology with over 300,000 procedures performed but continues to be chosen by the world's leading banks
Sepax is the only automated cord blood processing technology that :
- is the first cleared by the FDA and first approved device by the Japanese Ministry of Health
- has processed cord blood units used in thousands successful transplants
- that requires no operator intervention during processing
But most importantly, and this is a Fact :
'Every cord blood bank that has compared Sepax with other technologies has chosen Sepax'
|
|
|
|
|
